Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: A 20 month retrospective study at a Belgian University Hospital

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Schoevaerdts, Didier ^a   Bogaerts, Pierre ^a   Grimmelprez, Alexandre ^a   de Saint Hubert, Marie ^a   Delaere, Bénédicte ^a   Jamart, Jacques ^a   Swine, Christian ^a   Glupczynski, Youri ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFUROXIME; EXTENDED SPECTRUM BETA LACTAMASE; FLUCLOXACILLIN; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEMOCILLIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ABDOMINAL INFECTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BELGIUM; CHRONIC KIDNEY FAILURE; COMORBIDITY; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DISEASE SEVERITY; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION RISK; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; SEPTICEMIA; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; DRUG EFFECT; ENZYMOLOGY; FOLLOW UP; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; STATISTICS;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BELGIUM; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78651262576     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-12     Document Type: Article

References (41)

1. Cohen ML. Changing patterns of infectious disease. Nature 2000, 406:762-767. 10.1038/35021206, 10963605.
2. Struelens MJ, Mertens R. National survey of methicillin-resistant Staphylococcus aureus in Belgian hospitals: detection methods, prevalence trends and infection control measures. The Groupement pour le Depistage, l'Etude et la Prevention des Infections Hospitalieres. Eur J Clin Microbiol Infect Dis 1994, 13(1):56-63. 10.1007/BF02026128, 8168565.
3. Hoefnagels-Schuermans A, Niclaes L, Buntinx F, Suetens C, Jans B, Verhaegen J, Van Eldere J. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in nursing homes: a cross-sectional study. Infect Control Hosp Epidemiol 2002, 23(9):546-549. 10.1086/502105, 12269455.
4. Denis O, Jans B, Deplano A, Nonhoff C, De Ryck R, Suetens C, Struelens MJ. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. J Antimicrob Chemother 2009, 64(6):1299-1306. 10.1093/jac/dkp345, 19808236.
5. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42(7):925-934. 10.1086/500936, 16511754.
6. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004, 42(3):1089-1094. 10.1128/JCM.42.3.1089-1094.2004, 356843, 15004058.
7. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, de Cueto M, Rios MJ, Hernandez JR, Pascual A. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006, 43(11):1407-1414. 10.1086/508877, 17083012.
8. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3):159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
9. Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis 2006, 42(suppl 4):S153-163. 10.1086/500662, 16544266.
10. Jans B, Glupczynski Y, . GDEPIH Rapport de Surveillance d'Enterobacter aerogenes Multi-Résistant (MREA) dans les hôpitaux belges: deuxième semestre 2006. Rapports de l'Institut Scientifique de Santé Publique, Section Epidémiologie Surveillance Nationale des Infections Hospitalières 2006, GDEPIH.
11. Jans B, Glupczynski Y, . GDEPIH Rapport de Surveillance d'Enterobacter aerogenes Multi-Résistant (MREA) dans les hôpitaux belges: premier semestre 2008. Rapports de l'Institut Scientifique de Santé Publique, Section Epidémiologie: Surveillance Nationale des Infections Hospitalières 2008, GDEPIH.
12. Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, Yinnon AM. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009, 30(6):534-542. 10.1086/597505, 19419270.
13. Salvi F, Miller MD, Grilli A, Giorgi R, Towers AL, Morichi V, Spazzafumo L, Mancinelli L, Espinosa E, Rappelli A, et al. A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc 2008, 56(10):1926-1931. 10.1111/j.1532-5415.2008.01935.x, 18811613.
14. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992, 41(3):237-248. 10.1016/0165-1781(92)90005-N, 1594710.
15. Lindgren M, Unosson M, Krantz AM, Ek AC. A risk assessment scale for the prediction of pressure sore development: reliability and validity. J Adv Nurs 2002, 38(2):190-199. 10.1046/j.1365-2648.2002.02163.x, 11940132.
16. Norton D, Mc Laren R, Exton-Smith AN. An Investigation of Geriatric Problems in Hospital. 1979, Churchill Livingstone, London, 3.
17. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility tests: Eigteenth informal supplement M100-S18. 2008, CLSI, Wayne PA, USA, Clinical and Laboratory Standards Institute.
18. Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008, 14(suppl 1):90-103. 10.1111/j.1469-0691.2007.01846.x, 18154532.
19. Cohen Stuart J, Dierikx C, Al Naiemi N, Karczmarek A, Van Hoek AH, Vos P, Fluit AC, Scharringa J, Duim B, Mevius D, et al. Rapid detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother 2010, 65(7):1317-81.
20. Rodriguez-Bano J, Alcala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tortola T, Mirelis B, Navarro G, Cuenca M, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 2008, 168(17):1897-1902. 10.1001/archinte.168.17.1897, 18809817.
21. Calbo E, Romani V, Xercavins M, Gomez L, Vidal CG, Quintana S, Vila J, Garau J. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 2006, 57(4):780-783. 10.1093/jac/dkl035, 16492721.
22. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004, 23(3):163-167. 10.1007/s10096-003-1084-2, 14986159.
23. Guillet M, Bille E, Lecuyer H, Taieb F, Masse V, Lanternier F, Lage-Ryke N, Talbi A, Degand N, Lortholary O, et al. Epidemiology of patients harboring extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE), on admission. Med Mal Infect 2010,
24. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002, 136(11):834-844.
25. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001, 32(8):1162-1171. 10.1086/319757, 11283805.
26. Ho PL, Chan WM, Tsang KW, Wong SS, Young K. Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes. Scand J Infect Dis 2002, 34(8):567-573. 10.1080/00365540210147516, 12238570.
27. Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J, Kim JH, Kim EC. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002, 46(5):1481-1491. 10.1128/AAC.46.5.1481-1491.2002, 127143, 11959586.
28. Ramphal R, Ambrose PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis 2006, 42(suppl 4):S164-172. 10.1086/500663, 16544267.
29. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006, 50(4):1257-1262. 10.1128/AAC.50.4.1257-1262.2006, 1426954, 16569837.
30. Potz NA, Hope R, Warner M, Johnson AP, Livermore DM. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother 2006, 58(2):320-326. 10.1093/jac/dkl217, 16735428.
31. Bertrand X, Mouchot L, Jebabli M, Bajolet O, Aho S, Blech MF, Eloy C, Floret N, Gayet S, Talon D, et al. Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum beta-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study. Eur J Clin Microbiol Infect Dis 2008, 27(11):1113-1117. 10.1007/s10096-008-0536-0, 18488258.
32. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14(suppl 1):144-153. 10.1111/j.1469-0691.2007.01850.x, 18154538.
33. Yu WL, Chuang YC, Walther-Rasmussen J. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 2006, 39(4):264-277.
34. Markovska R, Schneider I, Keuleyan E, Sredkova M, Ivanova D, Markova B, Lazarova G, Dragijeva E, Savov E, Haydouchka I, et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bulgarian hospitals. Microb Drug Resist 2008, 14(2):119-128. 10.1089/mdr.2008.0814, 18489242.
35. Machado E, Coque TM, Canton R, Novais A, Sousa JC, Baquero F, Peixe L. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 2007, 60(6):1370-1374. 10.1093/jac/dkm381, 17913717.
36. Munday CJ, Xiong J, Li C, Shen D, Hawkey PM. Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int J Antimicrob Agents 2004, 23(2):175-180. 10.1016/j.ijantimicag.2003.07.004, 15013044.
37. Zahar JR, Bille E, Schnell D, Lanternier F, Mechai F, Masse V, Nassif X, Lortholary O. Extension of beta-lactamases producing bacteria is a worldwide concern. Med Sci (Paris) 2009, 25(11):939-944.
38. Rodriguez-Villalobos H, Malaviolle V, Frankard J, De Mendonca R, Nonhoff C, Deplano A, Byl B, Struelens MJ. Emergence of CTX-M extended spectrum beta-lactamase-producing Escherichia coli in Belgium. Euro Surveill 2005, 10(2):E050224-050223.
39. Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, Montesinos I, de Mendonça R, Jans B, Glupczynski Y. Trends in Production of Extended-Spectrum β-Lactamases among Enterobacteriaceae of c linical interest: Results of a Nationwide Survey in Belgian hospitals. J Antimicrob Chemother 2010,
40. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Claeys G, Lontie M, Van Meensel B, Herman L, Haesebrouck F, et al. Characterization of Extended-Spectrum beta-Lactamases Produced by Escherichia coli Isolated from Hospitalized and Nonhospitalized Patients: Emergence of CTX-M-15-Producing Strains Causing Urinary Tract Infections. Microb Drug Resist
41. Schoevaerdts D, Glupczynski Y, Delaere B, Hecq JD, Swine C. Effect of a 5-year multidisciplinary collaborative program on antibiotic consumption in an acute geriatric ward. J Am Geriatr Soc 2007, 55(1):145-147. 10.1111/j.1532-5415.2006.01029.x, 17233713.